Trinity Biotech, Captia VZV IgG. Product code 2325600: 96 Tests; product code: 2325601: 480 tests...

FDA Device Recall #Z-2445-2012 — Class III — May 29, 2012

Recall Summary

Recall Number Z-2445-2012
Classification Class III — Low risk
Date Initiated May 29, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Location Jamestown, NY
Product Type Devices
Quantity 810 kits

Product Description

Trinity Biotech, Captia VZV IgG. Product code 2325600: 96 Tests; product code: 2325601: 480 tests. For in vitro diagnostic use. Intended for the detection and quantitative determination of IgG antibody to VZV in human sera.

Reason for Recall

The Positive Control for the Captia Varicella-Zoster Virus (VZV) IgG Kit has been reported as running high out of its assigned ISR range.

Distribution Pattern

Nationwide Distribution-including Puerto Rico and the states of AL, CA, IL, IN, MA, MD, NJ, OH, PA, TN, TX.

Lot / Code Information

Kit lot codes: 2325600-566, 2325601-566, 2325600-567, 2325601-567, 2325600-568

Other Recalls from Clark Laboratories, Inc. (dba,Trinity...

Recall # Classification Product Date
Z-0620-2019 Class II ultra2 Genesys Variants Analyzer, REF 03-01-004... Nov 1, 2018
Z-0623-2019 Class II Genesys 2 Reagent, REF 01-03-0022 intended to b... Nov 1, 2018
Z-0621-2019 Class II Genesys Analytical Column, REF 01-05-0017 inten... Nov 1, 2018
Z-0622-2019 Class II Genesys 1 Reagent, REF 01-03-0020 intended to b... Nov 1, 2018
Z-0624-2019 Class II Genesys Diluent Reagent, REF 01-03-0019 intende... Nov 1, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.